---
title: "Top 10 HK Stock Losers (2.27)"
description: "BAIRONG-W(06608) fell 18.78%, with a trading turnover 115.5 Million HKD, and a year-to-date fell 17.2%. BAO PHARMA-B(02659) fell 14.89%, with a trading turnover 67.0 Million HKD, and a year-to-date ro"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/277285759.md"
published_at: "2026-02-28T08:30:51.000Z"
---

# Top 10 HK Stock Losers (2.27)

> BAIRONG-W(06608) fell 18.78%, with a trading turnover 115.5 Million HKD, and a year-to-date fell 17.2%. BAO PHARMA-B(02659) fell 14.89%, with a trading turnover 67.0 Million HKD, and a year-to-date rose 99.7%. CEB WATER(01857) fell 12.5%, with a trading turnover 20.2 Million HKD, and a year-to-date fell 3.9%.

Hang Seng Index has rose 0.95%, with a year-to-date rose 3.9%; Hang Seng TECH Index has rose 0.56%, with a year-to-date fell 6.9%.

BAIRONG-W(06608) fell 18.78%, with a trading turnover 115.5 Million HKD, and a year-to-date fell 17.2%.

BAO PHARMA-B(02659) fell 14.89%, with a trading turnover 67.0 Million HKD, and a year-to-date rose 99.7%.

CEB WATER(01857) fell 12.5%, with a trading turnover 20.2 Million HKD, and a year-to-date fell 3.9%.

### Related Stocks

- [06608.HK - BAIRONG-W](https://longbridge.com/en/quote/06608.HK.md)
- [02659.HK - BAO PHARMA-B](https://longbridge.com/en/quote/02659.HK.md)
- [01857.HK - CEB WATER](https://longbridge.com/en/quote/01857.HK.md)
- [02706.HK - HAIZHI TECH GP](https://longbridge.com/en/quote/02706.HK.md)
- [02427.HK - GUANZE MEDICAL](https://longbridge.com/en/quote/02427.HK.md)
- [00400.HK - INGDAN](https://longbridge.com/en/quote/00400.HK.md)
- [00658.HK - C TRANSMISSION](https://longbridge.com/en/quote/00658.HK.md)
- [06166.HK - CIG](https://longbridge.com/en/quote/06166.HK.md)
- [03986.HK - GIGADEVICE](https://longbridge.com/en/quote/03986.HK.md)
- [02630.HK - VIGONVITA-B](https://longbridge.com/en/quote/02630.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| 中国光大水务发布了谨慎的 2025 财年业绩报告 | 中国光大水务发布了其 2025 财年的年度业绩报告，详细介绍了公司的运营和管理观点。该文件作为口头讨论的支持材料，并不构成证券交易的邀请。公司强调与信息相关的重大风险和不确定性，建议接收者在投资决策时自行判断。中国光大水务有限公司专注于水相 | [Link](https://longbridge.com/en/news/277145233.md) |
| 港股异动：海致科技集团大跌 20.51%，AI 热潮背后的估值风险与市场疲软如何影响股价？ | 海致科技集团大跌 20.51%；智谱大跌 21.52%，成交额达到 22.03 亿港币；MINIMAX-WP 跌 11.80%，成交额达到 15.38 亿港币；滴普科技跌 0.10%，成交额达到 42.62 百万港币；出门问问涨 1.54% | [Link](https://longbridge.com/en/news/276559642.md) |
| 高致死率尼帕病毒迎克星？国产新冠药 VV116 跨界显效，两家合作方回应现 “温差” | 一款国产新冠药 VV116 被证实对致死率高达 70% 的尼帕病毒具有显著抗病毒活性，动物实验显示可提升感染金黄地鼠的存活率至 66.7%。然而，合作方君实生物-U 与旺山旺水对此回应不一，前者未进行相关研究，后者则计划启动临床试验。受此消 | [Link](https://longbridge.com/en/news/273972298.md) |
| 港股异动：宝济药业-B 逆市涨后大跌 15.66%，市场对纳入恒生指数的乐观预期能否支撑？ | 宝济药业-B 跌 15.66%；信达生物涨 0.71%，成交额达到 6.08 亿港币；康方生物涨 4.71%，成交额达到 5.5 亿港币；百济神州跌 1.18%，成交额达到 5.36 亿港币；科伦博泰生物-B 涨 1.00%，市值达到 89 | [Link](https://longbridge.com/en/news/277146696.md) |
| 中国光大水务董事会将批准年度业绩并考虑派发股息 | 中国光大水务有限公司将于 2026 年 2 月 27 日召开董事会会议，以批准截至 2025 年 12 月 31 日的财年的年度业绩，并考虑分红支付。该公告于 2026 年 1 月 26 日通过香港证券交易所的发行人信息服务发布 | [Link](https://longbridge.com/en/news/273684497.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.